Terminal ileitis as a manifestation of immune reconstitution syndrome following HAART [1]

AIDS

Volumn 20, Issue 14, 2006, Pages 1903-1905

  Plasencia, Luciano Delgado ^a   Socas, Maria Del Mar Alonso ^a   Valls, Remedios Alemán ^a   Fernández, Eudaldo Miguel López Tomassetti ^a   Higuera, Ana Castellano ^a   Gutierrez, Alberto Bravo ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; FEMALE; GENITAL HERPES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEITIS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION; LETTER; PRIORITY JOURNAL; VERRUCA VULGARIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; ILEITIS; SYNDROME;

EID: 33748507978     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000244214.00704.3a     Document Type: Letter

References (15)

1. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42:418-427.
2. DeSimone JA, Pomenrantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133:447-454.
3. Michelet C, Arvieux C, Francois C, Besnier JM, Rogez JP, Breux JP, et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 1998; 12:1815-1822.
4. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282:2220-2226.
5. Shelburne SA III, Hamill RJ, Rodríguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81:213-227.
6. Berger BB, Weinberg RS, Tessler HH, Wyhinny GJ, Vygantas CM. Bilateral cytomegalovirus panuveitis after high-dose corticosteroid therapy. Am J Ophthalmol 1979; 88:1020-1025.
7. Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med 1980; 93:664-670.
8. Vento S, Cainelli F, Mirandola F, Cosco L, Di Perri G, Solbiati M, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-93.
9. Rozenbaum R, Golcaves AJ. Clinical epidemiologic study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18:369-380.
10. Carr A, Emery S, Kelleher A, Law M, Cooper DA. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:320-326.
11. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173:321-329.
12. Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A, et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998; 27:1510-1513.
13. Foulon G, Wislez M, Naccache JM, Blanc FX, Rabbat A, Israelbiet D, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:418-425.
14. Price P, Morahan G, Huang D, Stone E, Cheong KY, Castley A, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16:2043-2047.
15. Shelburne SA III, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003; 5:67-79.